Publications
Specialty
Search
Oncology
09/04/2024
At the 2024 Society of Hematologic Oncology meeting, Eduardo Rego, MD, shares his interest in reviewing data on novel research in acute myeloid leukemia treatment development, specifically the incorporation of immunological approaches.
EMS World Américas
09/04/2024
Dispositivos automáticos de RCP.
EP Lab Digest
09/04/2024
AliMed Press Release
EMS World Américas
09/04/2024
La jornada hacia una mayor diversidad e inclusión.
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
09/04/2024
With inclusion in both the ESC and AHA/ACC clinical guidelines as a recommended option for when symptoms persist after first-line therapy, CAMZYOS is a standard of care for symptomatic oHCM.
Oncology
09/04/2024
Eduardo Rego, MD, shares expert insight into International Consortium on Acute Leukemia research on improving the outcomes of therapy for patients with AML treated in Latin America compared to the outcomes of those treated in the US and Europe.
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
09/04/2024
Kerendia is the first-and-only non-steroidal mineralocorticoid receptor antagonist (MRA) to meet a primary composite cardiovascular endpoint in a Phase III trial investigating patients with HF and LVEF ≥40%.(1)
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
09/04/2024
Cleerly has pioneered the development of several leading FDA-approved softwares that use coronary computed tomography angiography (CCTA) images with advanced AI algorithms to detect ischemia and stenosis, and identify, quantify, and categorize plaque.
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
09/04/2024
AliMed's contract covers an extensive range of radiation protection products, featuring off-the-shelf Grab 'n Go™ Aprons with same-day shipping and fully customizable Perfect Fit™ Aprons with tailored sizing and personalization options.
First Report Managed Care, Population Health
09/04/2024
This is a continuation of our Behind the Bill on the FDA’s new guidance for biosimilar interchangeability.
Advances in Inflammatory Bowel Disease Network
09/03/2024
Dr Erin Forster of the Medical University of South Carolina joins IBD Drive Time hosts Dr Millie Long and Dr Raymond Cross to review results of the trials for risankizumab in ulcerative colitis and discuss its positioning in treatment.
First Report Managed Care
09/03/2024
Obesity, traditionally recognized as a significant public health threat due to its association with numerous metabolic, inflammatory, and psychosocial conditions, is now emerging as a complex factor in the development and progression of abdominal aortic aneurysm (AAA), according to a review published in Frontiers in Endocrinology.
EP Lab Digest
09/03/2024
Asundexian 50 mg daily was inferior to apixaban for stroke and systemic embolism prevention in high-risk patients with atrial fibrillation (AF), according to late-breaking research presented in a Hot Line session today at ESC Congress 2024.
EP Lab Digest
09/03/2024
European Society of Cardiology Press Release
London, United Kingdom – 1 September 2024: Edoxaban monotherapy reduced net adverse clinical events compared with edoxaban plus a single antiplatelet agent, when used as long-term antithrombotic therapy, in patients with high-risk atrial fibrillation (AF) and stable coronary artery disease (CAD), according to late-breaking research presented in a Hot Line session today at ESC Congress 2024.1 The EPIC-CAD trial is simultaneously published in the New England Journal of Medicine.
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
09/03/2024
Minneapolis Heart Institute Foundation® (MHIF) announced the first enrollments in the Precise Procedural and PCI Plan (P4) Research Trial evaluating the potential for advanced cardiovascular imaging to enhance patient care.
EP Lab Digest
09/03/2024
European Society of Cardiology Press Release
London, United Kingdom – 1 September 2024: Telemedicine support to village doctors could hold the key to improving access to care for China’s rural elderly at risk for developing potentially life-threatening complications resulting from untreated atrial fibrillation, according to late breaking research presented in a Hot Line Session at this year’s ESC Congress 2024 in London, UK (30 Aug – 2 Sept).
First Report Managed Care
09/03/2024
Stereotactic MR-guided radiotherapy shows promise as an effective treatment for upper tract urothelial carcinoma (UTUC), particularly in patients who are not candidates for surgery, according to a case study presented in Frontiers in Oncology.
EP Lab Digest
09/03/2024
European Society of Cardiology Press Release
London, United Kingdom – 1 September 2024: Adherence to atrial fibrillation (AF) guideline recommendations was found to be poor in clinical practice across Europe, but a structured educational programme for healthcare professionals improved implementation of heart rhythm control recommendations in patients, according to late-breaking research presented in a Hot Line session today at the ESC Congress 2024.1
EP Lab Digest
09/03/2024
European Society of Cardiology Press Release
EP Lab Digest
09/03/2024
European Society of Cardiology Press Release
London, United Kingdom – 2 September 2024: A catheter ablation procedure widely used to treat the most common heart rhythm disorder significantly reduces the burden of atrial fibrillation (AF) and results in clinically important improvements in symptoms and quality of life compared with a sham (placebo) procedure, according to late breaking research presented in a Hot Line Session at this year’s ESC Congress 2024 in London, UK (30 Aug – 2 Sept).